Erratum for the research article "The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super-enhancer activity and the PI3K/AKT/mTOR signalling in pancreatic ductal adenocarcinoma: A hypothesis-generating study" by Huang et al

Affiliations

• ¹ Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
• ² School of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, China.
• ³ Department of Pathology, Chinese PLA General Hospital, Beijing, China.
• ⁴ Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China.
• ⁵ Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
• ⁶ Department of General Surgery, Shanghai Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.